Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Drug Products containing PREVACID NAPRAPAC 250 (COPACKAGED) listed with Health Canada. Original Data : Health Canada Website

Client Email

Product

PREVACID NAPRAPAC 250 (COPACKAGED)
Naproxen
Canada

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

PREVACID NAPRAPAC 250 (COPACKAGED)

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

102 API Suppliers, 39 USDMF, 26 CEP/COS, 18 JDMF, 23 EU WC, 20 KDMF, 20 NDC API, 57 Listed Suppliers, $ API Reference Price

102 API Suppliers
39 USDMF
26 CEP/COS
18 JDMF
23 EU WC
20 KDMF
20 NDC API
57 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

23 API Suppliers

23 API Suppliers

FINISHED DOSAGE FORMULATIONS

736 FDF Dossiers, 66 FDA Orange Book, 462 Europe, 27 Canada, 37 Australia, 37 South Africa, 107 Listed Dossiers

736 FDF Dossiers
66 FDA Orange Book
462 Europe
27 Canada
37 Australia
37 South Africa
107 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 30MG, CAPSULE, DELAYED REL PELLETS;ORAL - 15MG, CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, DELAYED REL PELLETS;ORAL - 30MG
CAPSULE, DELAYED REL PELLETS;ORAL - 15MG
CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Evonik, 8 Rochem International Inc, 22 SPI Pharma, 2 Seqens, 11 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 2 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 14 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 26 BASF, 1 Bioplus Life Sciences, 2 Clariant, 14 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 3 Finar, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 13 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 40 Roquette, 16 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

98 Fillers, Diluents & Binders, 74 Coating Systems & Additives, 44 Thickeners and Stabilizers, 43 Direct Compression, 41 Controlled & Modified Release, 38 Taste Masking, 32 Solubilizers, 29 Film Formers & Plasticizers, 24 Granulation, 24 Lubricants & Glidants, 23 Disintegrants & Superdisintegrants, 23 Topical, 23 Parenteral, 21 Chewable & Orodispersible Aids, 20 Co-Processed Excipients, 12 Emulsifying Agents, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 8 API Stability Enhancers, 7 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

98 Fillers, Diluents & Binders
74 Coating Systems & Additives
44 Thickeners and Stabilizers
43 Direct Compression
41 Controlled & Modified Release
38 Taste Masking
32 Solubilizers
29 Film Formers & Plasticizers
24 Granulation
24 Lubricants & Glidants
23 Disintegrants & Superdisintegrants
23 Topical
23 Parenteral
21 Chewable & Orodispersible Aids
20 Co-Processed Excipients
12 Emulsifying Agents
9 Empty Capsules
8 Surfactant & Foaming Agents
8 API Stability Enhancers
7 Rheology Modifiers
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 191 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
191 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 408 Finished Drug Prices, 1 Annual Reports

2 US Medicaid Prescriptions
408 Finished Drug Prices
1 Annual Reports

MARKET PLACE

15 APIs, 10 FDF Dossiers

15 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 27 Health Canada Patents

2 US Patents
27 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 15 Others

2 EDQM
1 USP
15 Others

ANALYTICAL

1 BioAnalytical Methods, 4 Analytical Methods

1 BioAnalytical Methods
4 Analytical Methods

$ API Ref.Price (USD/KG) : 94 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

27 All

01 1AA PHARMA INC

02 2APOTEX INC

03 1LABORATOIRE RIVA INC.

04 2MANTRA PHARMA INC

05 2MYLAN PHARMACEUTICALS ULC

06 1PRO DOC LIMITEE

07 4Pharmascience Inc.

08 2SANDOZ CANADA INCORPORATED

09 2SANIS HEALTH INC

10 2SIVEM PHARMACEUTICALS ULC

11 2SUN PHARMA CANADA INC

12 4TAKEDA PHARMACEUTICALS AMERICA INC

13 2TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

27 All

01 23LANSOPRAZOLE

02 4Lansoprazole

filter Dosage Form Reset all filters

27 All

01 25CAPSULE (DELAYED RELEASE)

02 2TABLET (DELAYED-RELEASE)

filter Brand Name Reset all filters

27 All

01 1AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN

02 2APO-LANSOPRAZOLE

03 7LANSOPRAZOLE

04 2M-LANSOPRAZOLE

05 2MYLAN-LANSOPRAZOLE

06 2PMS-LANSOPRAZOLE

07 2PREVACID

08 2PREVACID FASTAB

09 1RIVA-LANSOPRAZOLE

10 2SANDOZ LANSOPRAZOLE

11 2TARO-LANSOPRAZOLE

12 2TEVA-LANSOPRAZOLE

FDF Dossiers
FDA Orange Book
Europe
Canada
Australia
South Africa
Listed Dossiers

List of Suppliers

Product Main Page

01

Pharmascience Inc.

Boulder Peptide 2024

Not Confirmed

Pharmascience Inc.

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Lansoprazole

Brand Name : PMS-LANSOPRAZOLE

Dosage Form : CAPSULE (DELAYED RELEASE)

Dosage Strength : 15MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

02

Pharmascience Inc.

Boulder Peptide 2024

Not Confirmed

Pharmascience Inc.

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Lansoprazole

Brand Name : PMS-LANSOPRAZOLE

Dosage Form : CAPSULE (DELAYED RELEASE)

Dosage Strength : 30MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

03

Pharmascience Inc.

Boulder Peptide 2024

Not Confirmed

Pharmascience Inc.

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Lansoprazole

Brand Name : LANSOPRAZOLE

Dosage Form : CAPSULE (DELAYED RELEASE)

Dosage Strength : 15MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

04

Pharmascience Inc.

Boulder Peptide 2024

Not Confirmed

Pharmascience Inc.

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Lansoprazole

Brand Name : LANSOPRAZOLE

Dosage Form : CAPSULE (DELAYED RELEASE)

Dosage Strength : 30MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

05

TAKEDA PHARMACEUTICALS AMERICA INC

Boulder Peptide 2024

Not Confirmed

TAKEDA PHARMACEUTICALS AMERICA INC

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

LANSOPRAZOLE

Brand Name : PREVACID

Dosage Form : CAPSULE (DELAYED RELEASE)

Dosage Strength : 15MG

Packaging : 30/100

Approval Date :

Application Number : 2165503

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

06

TAKEDA PHARMACEUTICALS AMERICA INC

Boulder Peptide 2024

Not Confirmed

TAKEDA PHARMACEUTICALS AMERICA INC

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

LANSOPRAZOLE

Brand Name : PREVACID

Dosage Form : CAPSULE (DELAYED RELEASE)

Dosage Strength : 30MG

Packaging : 30/100

Approval Date :

Application Number : 2165511

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

07

TAKEDA PHARMACEUTICALS AMERICA INC

Boulder Peptide 2024

Not Confirmed

TAKEDA PHARMACEUTICALS AMERICA INC

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

LANSOPRAZOLE

Brand Name : PREVACID FASTAB

Dosage Form : TABLET (DELAYED-RELEASE)

Dosage Strength : 15MG

Packaging : 30

Approval Date :

Application Number : 2249464

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

08

TAKEDA PHARMACEUTICALS AMERICA INC

Boulder Peptide 2024

Not Confirmed

TAKEDA PHARMACEUTICALS AMERICA INC

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

LANSOPRAZOLE

Brand Name : PREVACID FASTAB

Dosage Form : TABLET (DELAYED-RELEASE)

Dosage Strength : 30MG

Packaging : 30

Approval Date :

Application Number : 2249472

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

09

TEVA CANADA LIMITED

Boulder Peptide 2024

Not Confirmed

TEVA CANADA LIMITED

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

LANSOPRAZOLE

Brand Name : TEVA-LANSOPRAZOLE

Dosage Form : CAPSULE (DELAYED RELEASE)

Dosage Strength : 15MG

Packaging : 30/100

Approval Date :

Application Number : 2280515

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

TEVA CANADA LIMITED

Boulder Peptide 2024

Not Confirmed

TEVA CANADA LIMITED

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

LANSOPRAZOLE

Brand Name : TEVA-LANSOPRAZOLE

Dosage Form : CAPSULE (DELAYED RELEASE)

Dosage Strength : 30MG

Packaging : 30/100/500

Approval Date :

Application Number : 2280523

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?